Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Systemic L-citrulline prevents cerebral vasospasm in haptoglobin 2-2 transgenic mice after subarachnoid hemorrhage.

Pradilla G, Garzon-Muvdi T, Ruzevick JJ, Bender M, Edwards L, Momin EN, Thompson RC, Tamargo RJ.

Neurosurgery. 2012 Mar;70(3):747-56; discussion 756-7. doi: 10.1227/NEU.0b013e3182363c2f.

PMID:
21915076
2.

Controlled delivery of nitric oxide inhibits leukocyte migration and prevents vasospasm in haptoglobin 2-2 mice after subarachnoid hemorrhage.

Momin EN, Schwab KE, Chaichana KL, Miller-Lotan R, Levy AP, Tamargo RJ.

Neurosurgery. 2009 Nov;65(5):937-45; discussion 945. doi: 10.1227/01.NEU.0000356974.14230.B8.

PMID:
19834407
3.

Vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice can be prevented with a glutathione peroxidase mimetic.

Froehler MT, Kooshkabadi A, Miller-Lotan R, Blum S, Sher S, Levy A, Tamargo RJ.

J Clin Neurosci. 2010 Sep;17(9):1169-72. doi: 10.1016/j.jocn.2010.04.014. Epub 2010 Jun 11.

PMID:
20541941
4.

A glutamate receptor antagonist, S-4-carboxyphenylglycine (S-4-CPG), inhibits vasospasm after subarachnoid hemorrhage in haptoglobin 2-2 mice [corrected].

Garzon-Muvdi T, Pradilla G, Ruzevick JJ, Bender M, Edwards L, Grossman R, Zhao M, Rudek MA, Riggins G, Levy A, Tamargo RJ.

Neurosurgery. 2013 Oct;73(4):719-28; discussion 729. doi: 10.1227/NEU.0000000000000080. Erratum in: Neurosurgery. 2013 Dec;73(6):E1098.

5.

Role of oxidized LDL and lectin-like oxidized LDL receptor-1 in cerebral vasospasm after subarachnoid hemorrhage.

Matsuda N, Ohkuma H, Naraoka M, Munakata A, Shimamura N, Asano K.

J Neurosurg. 2014 Sep;121(3):621-30. doi: 10.3171/2014.5.JNS132140. Epub 2014 Jun 20.

PMID:
24949677
6.

Haptoglobin 2-2 genotype determines chronic vasospasm after experimental subarachnoid hemorrhage.

Chaichana KL, Levy AP, Miller-Lotan R, Shakur S, Tamargo RJ.

Stroke. 2007 Dec;38(12):3266-71. Epub 2007 Oct 25.

7.

Attenuation of experimental subarachnoid hemorrhage--induced cerebral vasospasm by the adenosine A2A receptor agonist CGS 21680.

Lin CL, Shih HC, Lieu AS, Lee KS, Dumont AS, Kassell NF, Howng SL, Kwan AL.

J Neurosurg. 2007 Mar;106(3):436-41.

PMID:
17367066
8.

Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.

Atalay B, Caner H, Cekinmez M, Ozen O, Celasun B, Altinors N.

Neurosurgery. 2006 Nov;59(5):1102-7; discussion 1107-8.

PMID:
17143244
9.

The effect of an adenosine A1 receptor agonist in the treatment of experimental subarachnoid hemorrhage-induced cerebrovasospasm.

Lin CL, Su YF, Dumont AS, Shih HC, Lieu AS, Howng SL, Lee KS, Kwan AL.

Acta Neurochir (Wien). 2006 Aug;148(8):873-9; discussion 879. Epub 2006 Jun 23.

PMID:
16791438
10.

Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage.

McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, Pelligrino DA, Warner DS.

Stroke. 2002 Dec;33(12):2950-6.

11.

Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage.

Stoodley M, Weihl CC, Zhang ZD, Lin G, Johns LM, Kowalczuk A, Ghadge G, Roos RP, Macdonald RL.

Neurosurgery. 2000 May;46(5):1193-202; discussion 1202-3.

PMID:
10807252
12.

Magnesium lithospermate B alleviates the production of endothelin-1 through an NO-dependent mechanism and reduces experimental vasospasm in rats.

Chang CZ, Wu SC, Kwan AL, Hwang SL, Howng SL.

Acta Neurochir (Wien). 2011 Nov;153(11):2211-7. doi: 10.1007/s00701-011-1082-6. Epub 2011 Aug 11.

PMID:
21833783
13.

Genetic elimination of eNOS reduces secondary complications of experimental subarachnoid hemorrhage.

Sabri M, Ai J, Lass E, D'abbondanza J, Macdonald RL.

J Cereb Blood Flow Metab. 2013 Jul;33(7):1008-14. doi: 10.1038/jcbfm.2013.49. Epub 2013 Apr 3.

14.

Endothelial nitric oxide synthase mediates endogenous protection against subarachnoid hemorrhage-induced cerebral vasospasm.

Vellimana AK, Milner E, Azad TD, Harries MD, Zhou ML, Gidday JM, Han BH, Zipfel GJ.

Stroke. 2011 Mar;42(3):776-82. doi: 10.1161/STROKEAHA.110.607200. Epub 2011 Feb 11.

15.

Elevated level of endothelin-1 in cerebrospinal fluid and lack of nitric oxide in basilar arterial plasma associated with cerebral vasospasm after subarachnoid haemorrhage in rabbits.

Neuschmelting V, Marbacher S, Fathi AR, Jakob SM, Fandino J.

Acta Neurochir (Wien). 2009 Jul;151(7):795-801; discussion 801-2. doi: 10.1007/s00701-009-0350-1. Epub 2009 May 5.

PMID:
19415172
16.

Uncoupling of endothelial nitric oxide synthase after experimental subarachnoid hemorrhage.

Sabri M, Ai J, Knight B, Tariq A, Jeon H, Shang X, Marsden PA, Loch Macdonald R.

J Cereb Blood Flow Metab. 2011 Jan;31(1):190-9. doi: 10.1038/jcbfm.2010.76. Epub 2010 Jun 2.

17.

Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits.

Pradilla G, Thai QA, Legnani FG, Hsu W, Kretzer RM, Wang PP, Tamargo RJ.

Neurosurgery. 2004 Dec;55(6):1393-9; discussion 1399-1400.

PMID:
15574221
19.

Systemic administration of simvastatin after the onset of experimental subarachnoid hemorrhage attenuates cerebral vasospasm.

McGirt MJ, Pradilla G, Legnani FG, Thai QA, Recinos PF, Tamargo RJ, Clatterbuck RE.

Neurosurgery. 2006 May;58(5):945-51; discussion 945-51.

PMID:
16639331
20.

Leflunomide prevents vasospasm secondary to subarachnoid haemorrhage.

Belen D, Besalti O, Yiğitkanli K, Kösemehmetoğlu K, Simşek S, Bolay H.

Acta Neurochir (Wien). 2007 Oct;149(10):1041-7; discussion 1047-8. Epub 2007 Sep 17.

PMID:
17876498

Supplemental Content

Support Center